Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences

Author:

Aiello Bowles Erin J.1ORCID,Kroenke Candyce H.2ORCID,Chubak Jessica1ORCID,Bhimani Jenna3ORCID,O'Connell Kelli3ORCID,Brandzel Susan1ORCID,Valice Emily2ORCID,Doud Rachael1ORCID,Theis Mary Kay1ORCID,Roh Janise M.2ORCID,Heon Narre34ORCID,Persaud Sonia3ORCID,Griggs Jennifer J.5ORCID,Bandera Elisa V.6ORCID,Kushi Lawrence H.2ORCID,Kantor Elizabeth D.3ORCID

Affiliation:

1. 1Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.

2. 2Division of Research, Kaiser Permanente Northern California, Oakland, California.

3. 3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

4. 4Office of Faculty Professional Development, Diversity and Inclusion, Columbia University Irving Medical Center, New York, New York.

5. 5Departments of Internal Medicine, Hematology and Oncology Division, and Health Management and Policy, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.

6. 6Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, Rutgers, the State University of New Jersey, New Brunswick, New Jersey.

Abstract

Abstract Background: We updated algorithms to identify breast cancer recurrences from administrative data, extending previously developed methods. Methods: In this validation study, we evaluated pairs of breast cancer recurrence algorithms (vs. individual algorithms) to identify recurrences. We generated algorithm combinations that categorized discordant algorithm results as no recurrence [High Specificity and PPV (positive predictive value) Combination] or recurrence (High Sensitivity Combination). We compared individual and combined algorithm results to manually abstracted recurrence outcomes from a sample of 600 people with incident stage I–IIIA breast cancer diagnosed between 2004 and 2015. We used Cox regression to evaluate risk factors associated with age- and stage-adjusted recurrence rates using different recurrence definitions, weighted by inverse sampling probabilities. Results: Among 600 people, we identified 117 recurrences using the High Specificity and PPV Combination, 505 using the High Sensitivity Combination, and 118 using manual abstraction. The High Specificity and PPV Combination had good specificity [98%, 95% confidence interval (CI): 97–99] and PPV (72%, 95% CI: 63–80) but modest sensitivity (64%, 95% CI: 44–80). The High Sensitivity Combination had good sensitivity (80%, 95% CI: 49–94) and specificity (83%, 95% CI: 80–86) but low PPV (29%, 95% CI: 25–34). Recurrence rates using combined algorithms were similar in magnitude for most risk factors. Conclusions: By combining algorithms, we identified breast cancer recurrences with greater PPV than individual algorithms, without additional review of discordant records. Impact: Researchers should consider tradeoffs between accuracy and manual chart abstraction resources when using previously developed algorithms. We provided guidance for future studies that use breast cancer recurrence algorithms with or without supplemental manual chart abstraction.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3